SCHEMBL28680248

SCHEMBL28680248

O=[N+]([O-])c1cc(Br)cc2[c]c[nH]c12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 1/20 0.38
FBP1 P09467 1/20 0.37
AKR1B1 P15121 1/20 0.36
S100A4 P26447 1/20 0.36
TRPV1 Q8NER1 1/20 0.36
ALDH1A1 P00352 4/20 0.33
MAPT P10636 3/20 0.33
MEN1 O00255 1/20 0.33
HTT P42858 1/20 0.33
KMT2A Q03164 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
GPR35 Q9HC97 3/20 0.32
CYP3A4 P08684 2/20 0.32
CYP1A2 P05177 2/20 0.32
GRIN2D O15399 2/20 0.31
GRIN3B O60391 2/20 0.31
GRIN1 Q05586 2/20 0.31
GRIN2A Q12879 2/20 0.31
GRIN2B Q13224 2/20 0.31
GRIN2C Q14957 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL835945 0.72 TDP1 (0.44) S100A4ALDH1A1MAPTMEN1KMT2A
SCHEMBL4852222 0.72 CYP3A4 (0.32) CYP3A4TSHR
SCHEMBL9740775 0.72 GRIN2D (0.34) ALDH1A1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL1983087 0.68 S100A4 (0.40) ERN1FBP1AKR1B1S100A4TRPV1
SCHEMBL19327235 0.67 ERN1 (0.57) ERN1FBP1AKR1B1S100A4TRPV1
SCHEMBL9959976 0.67 CYP3A4 (0.42) ERN1FBP1AKR1B1S100A4TRPV1
SCHEMBL2768922 0.66 FBP1 (0.42) ERN1FBP1AKR1B1S100A4TRPV1
SCHEMBL11796324 0.65 ERN1 (0.50) ERN1AKR1B1S100A4TRPV1ALDH1A1
SCHEMBL18862781 0.65 ERN1 (0.50) ERN1FBP1AKR1B1S100A4TRPV1
SCHEMBL221077 0.65 ALDH1A1 (0.57) ERN1AKR1B1S100A4TRPV1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113816962-A Synthesis of Bruton's tyrosine kinase inhibitors 药品循环有限责任公司 2021-12-21 CN disclosed